CoRegen, Inc.
6 private offerings reported to the SEC on Form D since 2016, $134.3M sold in all. Biotech, TX.
- Form D offerings: 6
- Reported sold: $134.3M
- Newest: Feb 26, 2026
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Feb 26, 2026 | $13.5M | $13.5M | CoRegen, Inc.Biotech · TX | Not amended | 0002012886-26-000003 |
| May 22, 2025 | $62.6M | $62.6M | CoRegen, Inc.Biotech · CO | Not amended | 0002012886-25-000003 |
| Feb 28, 2025 | $20.8M | $20.8M | CoRegen, Inc.Biotech · CO | Not amended | 0002012886-25-000001 |
| Feb 28, 2025 | $10.0M | $10.0M | CoRegen, Inc.Biotech · CO | Not amended | 0002012886-25-000002 |
| Mar 8, 2024 | $12.9M | $12.9M | CoRegen, Inc.Biotech · CO | Not amended | 0002012886-24-000002 |
| Feb 22, 2024 | $14.5M | Open-ended | CoRegen, Inc.Biotech · CO | Not amended | 0002012886-24-000001 |
SEC Profile
From the company's EDGAR record- Business address
- Houston, Tx
- Incorporated in
- DE
- All SEC filings
- CIK 2012886 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR